Comparison of propofol , droperidol , and metoclopramide for <font color="red">prophylaxis_1</font> <font color="red">of_1</font> <font color="red">postoperative_2</font> <font color="red">nausea_2</font> <font color="red">and_2</font> <font color="red">vomiting_2</font> <font color="red">after_2</font> <font color="red">breast_3</font> <font color="red">cancer_3</font> <font color="red">surgery_2</font> <font color="red">:_2</font> a prospective , randomized , double - blind , placebo - controlled study in <font color="red">Japanese_4</font> <font color="red">patients_4</font> <font color="red">._4</font> 
<br>
<br> BACKGROUND <font color="red">Breast_1</font> <font color="red">cancer_1</font> <font color="red">surgery_1</font> <font color="red">performed_1</font> <font color="red">with_1</font> <font color="red">the_1</font> <font color="red">patient_3</font> <font color="red">under_2</font> <font color="red">general_2</font> <font color="red">anesthesia_2</font> <font color="red">has_1</font> <font color="red">been_1</font> <font color="red">associated_1</font> <font color="red">with_1</font> <font color="red">a_1</font> <font color="red">relatively_1</font> <font color="red">high_1</font> <font color="red">incidence_1</font> <font color="red">of_1</font> <font color="red">postoperative_1</font> <font color="red">nausea_1</font> <font color="red">and_1</font> <font color="red">vomiting_1</font> <font color="red">(_1</font> <font color="red">PONV_1</font> <font color="red">)_1</font> <font color="red">._1</font> Between <font color="red">60%_1</font> <font color="red">and_1</font> <font color="red">80%_1</font> <font color="red">of_1</font> <font color="red">patients_2</font> <font color="red">who_1</font> <font color="red">undergo_1</font> <font color="red">mastectomy_1</font> <font color="red">(_1</font> <font color="red">with_1</font> <font color="red">axillary_1</font> <font color="red">dissection_1</font> <font color="red">)_1</font> <font color="red">experience_1</font> <font color="red">PONV_1</font> <font color="red">._1</font> We previously reported that propofol at a subhypnotic dose of 0.5 mg / kg was more effective than placebo in preventing PONV in women who undergo mastectomy . 
<br> OBJECTIVE The purpose of this study was to compare the efficacy of a subhypnotic dose of propofol with the conventional antiemetics droperidol and metoclopramide for the prophylaxis of PONV after <font color="red">breast_2</font> <font color="red">cancer_2</font> <font color="red">surgery_2</font> <font color="red">in_2</font> <font color="red">Japanese_2</font> <font color="red">patients_2</font> <font color="red">._2</font> <font color="red">
<br>_1</font> METHODS In this prospective , randomized , double - blind , placebo - controlled study , <font color="red">Japanese_3</font> <font color="red">women_3</font> were randomized to <font color="red">1_1</font> <font color="red">of_1</font> <font color="red">4_1</font> <font color="red">groups_1</font> to receive IV administration of propofol 0.5 mg / kg , droperidol 20 microg / kg , metoclopramide 0.2 mg / kg , or placebo ( isotonic saline ) immediately after skin suture . <font color="red">A_1</font> <font color="red">standard_1</font> <font color="red">general_1</font> <font color="red">anesthetic_1</font> <font color="red">technique_1</font> <font color="red">,_1</font> <font color="red">including_1</font> <font color="red">sevoflurane_1</font> <font color="red">and_1</font> <font color="red">air_1</font> <font color="red">in_1</font> <font color="red">oxygen_1</font> <font color="red">,_1</font> <font color="red">was_1</font> <font color="red">used_1</font> <font color="red">._1</font> All episodes of PONV during the first 24 hours after anesthesia administration were recorded by an investigator who was blinded to treatment assignment . The investigator questioned the <font color="red">patients_1</font> as to whether they experienced extrapyramidal symptoms . To maintain the integrity of the study results , none of the patients received preanesthetic medication . 
<br> RESULTS <font color="red">A_2</font> <font color="red">total_3</font> <font color="red">of_3</font> <font color="red">100_6</font> <font color="red">women_6</font> <font color="red">(_5</font> <font color="red">mean_5</font> <font color="red">[_5</font> <font color="red">SD_5</font> <font color="red">]_5</font> <font color="red">age_5</font> <font color="red">,_5</font> <font color="red">52_5</font> <font color="red">[_5</font> <font color="red">7_5</font> <font color="red">]_5</font> <font color="red">years_5</font> <font color="red">;_5</font> <font color="red">height_5</font> <font color="red">,_5</font> <font color="red">154_5</font> <font color="red">[_5</font> <font color="red">6_5</font> <font color="red">]_5</font> <font color="red">cm_5</font> <font color="red">;_5</font> <font color="red">weight_5</font> <font color="red">,_5</font> <font color="red">54_5</font> <font color="red">[_5</font> <font color="red">7_5</font> <font color="red">]_5</font> <font color="red">kg_5</font> <font color="red">)_5</font> <font color="red">were_2</font> <font color="red">included_2</font> <font color="red">in_2</font> <font color="red">the_2</font> <font color="red">study_2</font> <font color="red">._2</font> Each study <font color="red">group_1</font> comprised 25 <font color="red">patients_1</font> <font color="red">._1</font> There were no significant differences between treatment <font color="red">groups_1</font> with regard to patient demographics , surgery type , or awakening time . The prevalences of PONV 0 to 24 hours after anesthesia were 28% with propofol ( P = 0.005 ) , 32% with droperidol ( P = 0.011 ) , and 60% with metoclopramide ( P = NS ) , compared with placebo ( 68% ) . No significant difference in the prevalence of PONV was found between <font color="red">patients_1</font> receiving propofol and those receiving droperidol , and propofol and droperidol were associated with significantly lower prevalences of PONV compared with metoclopramide ( P = 0.022 and P = 0.043 , respectively ) . Extrapyramidal symptoms were not reported in any of the groups . 
<br> CONCLUSIONS The prevalences of PONV were not significantly different between propofol 0.5 mg / kg and droperidol 20 microg / kg 0 to 24 hours after anesthesia in this small , select group of Japanese women who underwent breast cancer surgery . The prevalences of PONV were significantly lower with propofol and droperidol compared with metoclopramide 0.2 mg / kg and placebo .